|
LM_ID
|
Common Name
|
Systematic Name
|
Species Shorthand
|
Formula
|
Mass
|
|
LMFA03130209
|
(8R,12S,15R)-d9-11-IsoF[11S,14S]
|
(R,5Z,9E)-8-hydroxy-10-((2S,3S,5S)-3-hydroxy-5-((R)-1-hydroxyhexyl)tetrahydrofuran-2-yl)deca-5,9-dienoic acid
|
FA 20:3;O4
|
C20H34O6
|
370.235541
|
|
LMFA04020270
|
(4S,8S,11S)-d5-7-NeuroF[7S,10R]
|
(S,E)-4-hydroxy-6-((2S,3S,5R)-3-hydroxy-5-((S,3Z,6Z,9Z)-1-hydroxydodeca-3,6,9-trien-1-yl)tetrahydrofuran-2-yl)hex-5-enoic acid
|
FA 22:5;O4
|
C22H34O6
|
394.235541
|
|
LMFA04020293
|
(14S,17R,20S)-d18-13-NeuroF[13S,16S]
|
(4Z,7Z,10Z)-12-((2S,3S,5S)-5-((1R,4S,E)-1,4-dihydroxyhex-2-en-1-yl)-3-hydroxytetrahydrofuran-2-yl)dodeca-4,7,10-trienoic acid
|
FA 22:5;O4
|
C22H34O6
|
394.235541
|
|
LMFA04020377
|
(10R,13S,16R)-d11-14-NeuroF[14R,17R]
|
(4Z,7Z,10R,11E,13S)-10,13-dihydroxy-13-((2R,4R,5R)-4-hydroxy-5-((Z)-pent-2-en-1-yl)tetrahydrofuran-2-yl)trideca-4,7,11-trienoic acid
|
FA 22:5;O4
|
C22H34O6
|
394.235541
|
|
LMFA04020478
|
(5R,8S,11S)-d9-4-NeuroF[4S,7R]
|
3-((2S,3R,5R)-5-((1S,2E,4S,6Z,9Z,12Z)-1,4-dihydroxypentadeca-2,6,9,12-tetraen-1-yl)-3-hydroxytetrahydrofuran-2-yl)propanoic acid
|
FA 22:5;O4
|
C22H34O6
|
394.235541
|
|
LMFA04020418
|
(8S,11R,14R)-d12-7-NeuroF[7S,10R]
|
(Z)-6-((2S,3S,5R)-5-((1R,2E,4R,6Z,9Z)-1,4-dihydroxydodeca-2,6,9-trien-1-yl)-3-hydroxytetrahydrofuran-2-yl)hex-4-enoic acid
|
FA 22:5;O4
|
C22H34O6
|
394.235541
|
|
LMFA04020417
|
(8S,11R,14R)-d12-7-NeuroF[7S,10S]
|
(Z)-6-((2S,3S,5S)-5-((1R,2E,4R,6Z,9Z)-1,4-dihydroxydodeca-2,6,9-trien-1-yl)-3-hydroxytetrahydrofuran-2-yl)hex-4-enoic acid
|
FA 22:5;O4
|
C22H34O6
|
394.235541
|
|
LMFA03130167
|
(5S,8S,11S)-d6-9-IsoF[9S,12R]
|
(5S,8S,E)-5,8-dihydroxy-8-((2S,4S,5R)-4-hydroxy-5-((Z)-oct-2-en-1-yl)tetrahydrofuran-2-yl)oct-6-enoic acid
|
FA 20:3;O4
|
C20H34O6
|
370.235541
|
|
LMFA01020407
|
3-Hydroxy-11-methyl-stearic acid
|
3-Hydroxy-11-methyloctadecanoic acid
|
FA 19:0;O
|
C19H38O3
|
314.282096
|
|
LMFA01020407
|
3-Hydroxy-11-methyl-stearic acid
|
3-Hydroxy-11-methyloctadecanoic acid
|
FA 19:0;O
|
C19H38O3
|
314.282096
|
|
LMFA03110268
|
ent-8,11-diepi-8-A2-IsoP
|
(S,5Z,9E)-8-hydroxy-10-((1R,5S)-2-oxo-5-pentylcyclopent-3-en-1-yl)deca-5,9-dienoic acid
|
FA 20:5;O2
|
C20H30O4
|
334.214411
|
|
LMFA04010357
|
7,14-diepi-14-E4c-NeuroP
|
(Z)-6-((1S,2S,3R)-3-hydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopentyl)hex-4-enoic acid
|
FA 22:6;O3
|
C22H32O5
|
376.224976
|
|
LMFA02040027
|
(9S,12R,15S)-d10-13-PhytoF[13S,16R]
|
(9S,12R,E)-12-((2S,4S,5R)-5-ethyl-4-hydroxytetrahydrofuran-2-yl)-9,12-dihydroxydodec-10-enoic acid
|
FA 18:2;O4
|
C18H32O6
|
344.219891
|
|
LMFA03110215
|
8,11-diepi-8-E2t-IsoP
|
(R,5Z,9E)-8-hydroxy-10-((1R,2R,3R)-3-hydroxy-5-oxo-2-pentylcyclopentyl)deca-5,9-dienoic acid
|
FA 20:4;O3
|
C20H32O5
|
352.224976
|
|
LMFA02030022
|
16-epi-16-F1c-PhytoP
|
8-((1R,2S,3R,5S)-3,5-dihydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)cyclopentyl)octanoic acid
|
FA 18:2;O3
|
C18H32O5
|
328.224976
|
|
LMFA02030068
|
16-epi-16-J1-PhytoP
|
8-((1R,5R)-5-((R,E)-3-hydroxypent-1-en-1-yl)-4-oxocyclopent-2-en-1-yl)octanoic acid
|
FA 18:4;O2
|
C18H28O4
|
308.198761
|
|
LMFA03110223
|
8,11-diepi-8-D2c-IsoP
|
(R,5Z,9E)-8-hydroxy-10-((1S,2S,5S)-5-hydroxy-3-oxo-2-pentylcyclopentyl)deca-5,9-dienoic acid
|
FA 20:4;O3
|
C20H32O5
|
352.224976
|
|
LMFA04010076
|
ent-16-epi-13-F4c-NeuroP
|
(R,4Z,7Z,10Z,14E)-15-((1R,2R,3S,5R)-2-ethyl-3,5-dihydroxycyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240626
|
|
LMFA04010465
|
7-epi-4-J4-NeuroP
|
(S,E)-4-hydroxy-6-((1R,5S)-4-oxo-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopent-2-en-1-yl)hex-5-enoic acid
|
FA 22:7;O2
|
C22H30O4
|
358.214411
|
|
LMFA03130250
|
(5S,8R,12R)-d10-6-IsoF[6R,9S]
|
(S)-5-hydroxy-5-((2R,4R,5S)-4-hydroxy-5-((R,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)tetrahydrofuran-2-yl)pentanoic acid
|
FA 20:3;O4
|
C20H34O6
|
370.235541
|
|
LMFA02040091
|
(10S,13R,16S)-d14-9-PhytoF[9R,12S]
|
8-((2R,3S,5S)-5-((1R,4S,E)-1,4-dihydroxyhex-2-en-1-yl)-3-hydroxytetrahydrofuran-2-yl)octanoic acid
|
FA 18:2;O4
|
C18H32O6
|
344.219891
|
|
LMFA02040009
|
(9R,12R,15S)-d10-13-PhytoF[13R,16R]
|
(9R,12R,E)-12-((2R,4S,5R)-5-ethyl-4-hydroxytetrahydrofuran-2-yl)-9,12-dihydroxydodec-10-enoic acid
|
FA 18:2;O4
|
C18H32O6
|
344.219891
|
|
LMFA02040075
|
(10R,13R,16S)-d14-9-PhytoF[9R,12S]
|
8-((2R,3R,5S)-5-((1R,4S,E)-1,4-dihydroxyhex-2-en-1-yl)-3-hydroxytetrahydrofuran-2-yl)octanoic acid
|
FA 18:2;O4
|
C18H32O6
|
344.219891
|
|
LMFA02030052
|
16-epi-16-E1t-PhytoP
|
8-((1S,2R,3R)-3-hydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)octanoic acid
|
FA 18:3;O3
|
C18H30O5
|
326.209326
|
|
LMFA03110278
|
8-epi-5-J2-IsoP
|
(S,E)-5-hydroxy-7-((S,E)-2-((Z)-oct-2-en-1-ylidene)-3-oxocyclopentyl)hept-6-enoic acid
|
FA 20:5;O2
|
C20H30O4
|
334.214411
|
|
LMFA07070121
|
3S,5Z-hydroxydodecenoylcarnitine
|
3S-{[(5Z)-3-hydroxydodec-7-enoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 12:1;O
|
C19H35NO5
|
357.251524
|
|
LMFA07070121
|
3S,5Z-hydroxydodecenoylcarnitine
|
3S-{[(5Z)-3-hydroxydodec-7-enoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 12:1;O
|
C19H35NO5
|
357.251524
|
|
LMFA07070121
|
3S,5Z-hydroxydodecenoylcarnitine
|
3S-{[(5Z)-3-hydroxydodec-7-enoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 12:1;O
|
C19H35NO5
|
357.251524
|
|
LMFA04010261
|
13,20-diepi-20-D4c-NeuroP
|
(4Z,7Z,10Z)-12-((1S,2S,5S)-5-hydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)-3-oxocyclopentyl)dodeca-4,7,10-trienoic acid
|
FA 22:6;O3
|
C22H32O5
|
376.224976
|
|
LMFA04010284
|
ent-10-epi-7-E4c-NeuroP
|
(R,4Z,8E)-7-hydroxy-9-((1R,2R,3S)-3-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopentyl)nona-4,8-dienoic acid
|
FA 22:6;O3
|
C22H32O5
|
376.224976
|
|
LMFA04010106
|
14-F4t-NeuroP
|
(Z)-6-((1S,2R,3R,5S)-3,5-dihydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240626
|
|
LMFA04010316
|
ent-4-epi-11-E4c-NeuroP
|
3-((1R,2R,3S)-3-hydroxy-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopentyl)propanoic acid
|
FA 22:6;O3
|
C22H32O5
|
376.224976
|
|
LMFA04010223
|
ent-14-epi-14-D4t-NeuroP
|
(Z)-6-((1R,2S,5R)-5-hydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-3-oxocyclopentyl)hex-4-enoic acid
|
FA 22:6;O3
|
C22H32O5
|
376.224976
|
|
LMFA04010231
|
14-D4c-NeuroP
|
(Z)-6-((1R,2S,5S)-5-hydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-3-oxocyclopentyl)hex-4-enoic acid
|
FA 22:6;O3
|
C22H32O5
|
376.224976
|
|
LMFA04010094
|
ent-14-F4c-NeuroP
|
(Z)-6-((1S,2R,3S,5R)-3,5-dihydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240626
|
|
LMFA04010135
|
20-F4c-NeuroP
|
(4Z,7Z,10Z)-12-((1R,2S,3R,5S)-3,5-dihydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)cyclopentyl)dodeca-4,7,10-trienoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240626
|
|
LMFA03110319
|
ent-14-F2c-dihomo-IsoP
|
1a,1b-dihomo-8R,10S,14R-trihydroxy-12E,16Z-prostadienoic acid-cyclo[7S,11R]
|
FA 22:3;O3
|
C22H38O5
|
382.271926
|
|
LMFA07070122
|
2E,9Z-Hexadecadienoylcarnitine
|
3-[(2E,9Z)-hexadeca-2,9-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 16:2
|
C23H41NO4
|
395.303559
|
|
LMFA07070122
|
2E,9Z-Hexadecadienoylcarnitine
|
3-[(2E,9Z)-hexadeca-2,9-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 16:2
|
C23H41NO4
|
395.303559
|
|
LMFA07070122
|
2E,9Z-Hexadecadienoylcarnitine
|
3-[(2E,9Z)-hexadeca-2,9-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 16:2
|
C23H41NO4
|
395.303559
|
|
LMFA01160047
|
2-docosyl-3-hydroxy-heptatriaconta-20Z-enoic acid
|
2-docosyl-3-hydroxy-heptatriaconta-20Z-enoic acid
|
FA 59:1;O
|
C59H116O3
|
872.892447
|
|
LMFA01160047
|
2-docosyl-3-hydroxy-heptatriaconta-20Z-enoic acid
|
2-docosyl-3-hydroxy-heptatriaconta-20Z-enoic acid
|
FA 59:1;O
|
C59H116O3
|
872.892447
|
|
LMFA01160047
|
2-docosyl-3-hydroxy-heptatriaconta-20Z-enoic acid
|
2-docosyl-3-hydroxy-heptatriaconta-20Z-enoic acid
|
FA 59:1;O
|
C59H116O3
|
872.892447
|
|
LMFA01160065
|
2-tetracosyl-3-hydroxy-32-methoxy-33-methyl-nonatetracontanoic acid
|
2-tetracosyl-3-hydroxy-32-methoxy-33-methyl-nonatetracontanoic acid
|
FA 74:0;O2
|
C74H148O4
|
1101.137763
|
|
LMFA01160075
|
2-tetracosyl-3-hydroxy-32-oxo-33-methyl-henpentacontanoic acid
|
2-tetracosyl-3-hydroxy-32-oxo-33-methyl-henpentacontanoic acid
|
FA 76:1;O2
|
C76H150O4
|
1127.153413
|
|
LMFA01160107
|
2-docosyl-3-hydroxy-32,33-epoxy-34-methyl-pentacontanoic acid
|
2-docosyl-3-hydroxy-32,33-epoxy-34-methyl-pentacontanoic acid
|
FA 73:1;O2
|
C73H144O4
|
1085.106462
|
|
LMFA01160122
|
2-eicosyl-3-hydroxy-30-carboxy-triacontanoic acid
|
2-eicosyl-3-hydroxy-30-carboxy-triacontanoic acid
|
FA 51:1;O3
|
C51H100O5
|
792.757077
|
|
LMFA08030031
|
N-(3-oxo-pentanoyl)-homoserine lactone
|
N-(3-oxo-pentanoyl)-homoserine lactone
|
|
C9H13NO4
|
199.084459
|
|
LMFA08030037
|
N-(3-hydroxy-decanoyl)-homoserine lactone
|
N-(3-hydroxy-decanoyl)-homoserine lactone
|
|
C14H25NO4
|
271.178359
|
|
LMFA04010151
|
4-D4c-NeuroP
|
(S,E)-4-hydroxy-6-((1R,2S,5S)-5-hydroxy-3-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid
|
FA 22:6;O3
|
C22H32O5
|
376.224976
|